Back to User profile » Prof. Dr. Mart AFJ Van De Laar

Paper published by Prof. Dr. Mart AFJ Van De Laar:


Original Research

Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis

Van De Laar CJ, Oude Voshaar MAH, Fakhouri WKH, Zaremba-Pechmann L, De Leonardis F, De La Torre I, Van De Laar MAFJ

ClinicoEconomics and Outcomes Research 2020, 12:213-222

Published Date: 15 April 2020